Kolon TissueGene Wins Damages Lawsuit: Seoul High Court Mediation Finalized with Zero Payment Obligation

The Seoul High Court issued a mediation recommendation regarding the damages lawsuit filed in February 2026, and it became final as both parties did not object.
Under the mediation, the 220 plaintiffs abandoned their claims, and the company has no payment obligation.
This resolution eliminates a potential financial burden, positively impacting shareholder value by removing litigation risk.
[AI Summary]Kolon TissueGene secures a final ruling with zero liability relative to equity of about 222 billion KRW, blocking the possibility of substantial losses. The removal of litigation risk is expected to improve investor sentiment and support stock price stability.